Centurion Pipeline Co Revenue and Competitors

Midland, TX USA

Location

N/A

Total Funding

Energy/Oil

Industry

Estimated Revenue & Valuation

  • Centurion Pipeline Co's estimated annual revenue is currently $50.9M per year.(i)
  • Centurion Pipeline Co's estimated revenue per employee is $269,500

Employee Data

  • Centurion Pipeline Co has 189 Employees.(i)
  • Centurion Pipeline Co grew their employee count by -23% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$38M14123%N/AN/A
#2
$60.6M2254%N/AN/A
#3
$6.7M343%N/AN/A
#4
$11.2M516%N/AN/A
#5
$18.6M766%N/AN/A
#6
$7.3M3915%N/AN/A
#7
$42.3M15734%N/AN/A
#8
$18.6M764%N/AN/A
#9
$6.9M356%N/AN/A
#10
$5M290%N/AN/A
Add Company

What Is Centurion Pipeline Co?

Centurion Pipeline L.P. is a common carrier pipeline operator with approximately 2,900 miles of pipelines extending from southeast New Mexico across the Permian Basin of west Texas to Cushing, Oklahoma. The system has a throughput capacity of approximately 720,000 barrels per day. Additionally, Centurion Pipeline has approximately 120 unloading stations located at strategic points throughout New Mexico, Texas and Oklahoma to allow for additional volumes to be delivered into Centurion Pipeline's primary pipeline system.\n\nCenturion Pipeline is committed to respecting the environment, maintaining safety and upholding high standards of social responsibility throughout its operations. Our success is built on technical expertise, business acumen, strong partnerships and proven ability to deliver superior results.

keywords:N/A

N/A

Total Funding

189

Number of Employees

$50.9M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Centurion Pipeline Co News

2022-04-19 - Battered Biotech Firm CytRx Hires New CEO, Retools

Fifteen years ago, Brentwood-based biopharma company CytRx Corp. was ... investors that the company's drug pipeline could start delivering...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$49.8M18931%$250M
#2
N/A2069%N/A
#3
$51.1M2218%N/A
#4
$66.2M2237%N/A
#5
$60.6M2252%N/A